Increased percentages of t helper cells producing il-17 and monocytes expressing markers of alternative activation in patients with sepsis

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Brunialti, Milena Karina ^a   Santos, Michelle Carolina ^a   Rigato, Otelo ^a,b   Machado, Flavia Ribeiro ^a   Silva, Eliezer ^c   Salomao, Reinaldo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CD206 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 7 RECEPTOR; LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LECTIN; LEUKOCYTE ANTIGEN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; SEPSIS; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; VOLUNTEER; BIOSYNTHESIS; CELL COUNT; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION REGULATION; HELPER CELL; IMMUNOLOGY; MACROPHAGE; METABOLISM; MIDDLE AGED; PROGNOSIS;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; CELL COUNT; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-17; LECTINS, C-TYPE; MACROPHAGES; MALE; MANNOSE-BINDING LECTINS; MIDDLE AGED; MONOCYTES; PROGNOSIS; RECEPTORS, CELL SURFACE; SEPSIS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84861667506     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037393     Document Type: Article

References (53)

1. Salomao R, Martins PS, Brunialti MK, Fernandes Mda L, Martos LS, et al. (2008) TLR signaling pathway in patients with sepsis. Shock 30: 73-77.
2. Hotchkiss RS, Karl IE, (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348: 138-150.
3. Munoz C, Carlet J, Fitting C, Misset B, Blériot JP, et al. (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88: 1747-1754.
4. Rigato O, Salomao R, (2003) Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis. Shock 19: 113-116.
5. Salomao R, Brunialti MK, Kallás EG, Martins PS, Rigato O, et al. (2002) Lipopolysaccharide-cell interaction and induced cellular activation in whole blood of septic patients. J Endotoxin Res 8: 371-379.
6. Bettelli E, Korn T, Oukka M, Kuchroo VK, (2008) Induction and effector functions of T(H)17 cells. Nature 453: 1051-1057.
7. Sakaguchi S, Yamaguchi T, Nomura T, Ono M, (2008) Regulatory T cells and immune tolerance. Cell 133: 775-787.
8. Monneret G, Debard AL, Venet F, Bohe J, Hequet O, et al. (2003) A Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 31: 2068-2071.
9. Venet F, Pachot A, Debard AL, Bohé J, Bienvenu J, et al. (2004) Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25- lymphocytes. Crit Care Med 32: 2329-2331.
10. Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, et al. (2009) Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 35: 678-686.
11. Scumpia PO, Delano MJ, Kelly KM, O'Malley KA, Efron PA, et al. (2006) Increased natural CD4+CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol 177: 7943-7949.
12. Heuer JG, Zhang T, Zhao J, Ding C, Cramer M, et al. (2005) Adoptive transfer of in vitro-stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol 174: 7141-7146.
13. Hein F, Massin F, Cravoisy-Popovic A, Barraud D, Levy B, et al. (2010) The relationship between CD4+CD25+CD127- regulatory T cells and inflammatory response and outcome during shock states. Crit Care 14: R19.
14. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132.
15. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature 441: 235-238.
16. Stockinger B, Veldhoen M, Martin B, (2007) Th17 T cells linking innate and adaptive immunity. Semin Immunol 19: 353-361.
17. Gordon S, (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35.
18. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
19. Stein M, Keshav S, Harris N, Gordon S, (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176: 287-292.
20. Van Gorp H, Delputte PL, Nauwynck HJ, (2010) Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol Immunol 47: 1650-1660.
21. Pesce J, Kaviratne M, Ramalingam TR, Thompson RW, Urban JF Jr, et al. (2006) The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest 116: 2044-55.
22. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, et al. (2007) CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci USA 104: 19446-19451.
23. Lin RY, Astiz ME, Saxon JC, Rackow EC, (1993) Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest 104: 847-853.
24. Brunialti MK, Martins PS, Barbosa de Carvalho H, Machado FR, Barbosa LM, et al. (2006) TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 25: 351-357.
25. Monneret G, Lepape A, Voirin N, Bohé J, Venet F, et al. (2006) Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32: 1175-1183.
26. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, et al. (1995) Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85: 1341-1347.
27. Martins PS, Brunialti MK, Martos LS, Machado FR, Assunçao MS, et al. (2008) Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis. Crit Care 12: R25.
28. Cavaillon JM, Adib-Conquy M, (2006) Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 10: 233.
29. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655.
30. Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, et al. (1995) Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 86: 1408-1419.
31. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203: 1701-1711.
32. Beyer M, Classen S, Endl E, Kochanek M, Weihrauch MR, et al. (2011) Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3. Clin Dev Immunol 2011 734036.
33. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr, Hui JJ, et al. (2001) Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 166: 6952-696.
34. O'Sullivan ST, Lederer JA, Horgan AF, Chin DH, Mannick JA, et al. (1995) Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 222: 482-492.
35. Heidecke CD, Hensler T, Weighardt H, Zantl N, Wagner H, et al. (1999) Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg 178: 288-292.
36. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ, Koenen HJ, Cheng SC, et al. (2009) The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 5: 329-340.
37. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, et al. (2001) Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med 194: 519-527.
38. Huang W, Na L, Fidel PL, Schwarzenberger P, (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190: 624-631.
39. Flierl MA, Rittirsch D, Gao H, Hoesel LM, Nadeau BA, et al. (2008) Adverse functions of IL-17A in experimental sepsis. FASEB J 22: 2198-2205.
40. Bingold TM, Ziesché E, Scheller B, Sadik CD, Franck K, et al. (2010) Interleukin-22 detected in patients with abdominal sepsis. Shock 34: 337-340.
41. Martins PS, Kallas EG, Neto MC, Dalboni MA, Blecher S, et al. (2003) Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock 20: 208-212.
42. Salomao R, Brunialti MK, Gomes NE, Mendes ME, Diaz RS, et al. (2009) Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock. Crit Care Med 37: 132-139.
43. Venet F, Davin F, Guignant C, Larue A, Cazalis MA, et al. (2010) Early assessment of leukocyte alterations at diagnosis of septic shock. Shock 34: 358-363.
44. Groselj-Grenc M, Ihan A, Derganc M, (2008) Neutrophil and monocyte CD64 and CD163 expression in critically ill neonates and children with sepsis: comparison of fluorescence intensities and calculated indexes. Mediators Inflamm 2008 202646.
45. Møller HJ, Moestrup SK, Weis N, Wejse C, Nielsen H, et al. (2006) Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163. Crit Care Med 34: 2561-2566.
46. Gaïni S, Pedersen SS, Koldkaer OG, Pedersen C, Moestrup SK, et al. (2008) New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis. Clin Exp Immunol 151: 423-431.
47. Passlick B, Flieger D, Ziegler-Heitbrock HW, (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74: 2527-2534.
48. Gordon S, Taylor PR, (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964.
49. Serbina NV, Jia T, Hohl TM, Pamer EG, (2008) Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 26: 421-452.
50. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686.
51. Tippett E, Cheng WJ, Westhorpe C, Cameron PU, Brew BJ, et al. (2011) Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals. PLoS One 6: e19968.
52. Fernandes ML, Mendes ME, Brunialti MK, Salomao R, (2010) Human monocytes tolerant to LPS retain the ability to phagocytose bacteria and generate reactive oxygen species. Braz J Med Biol Res 43: 860-868.
53. Mendes ME, Baggio-Zappia GL, Brunialti MK, Fernandes MD, Rapozo MM, et al. (2011) Differential expression of toll-like receptor signaling cascades in LPS-tolerant human peripheral blood mononuclear cells. Immunobiology 216: 285-295.